sGC stimulator praliciguat suppresses stellate cell fibrotic transformation and inhibits fibrosis and inflammation in models of NASH

Endothelial dysfunction and reduced nitric oxide (NO) signaling are a key element of the pathophysiology of nonalcoholic steatohepatitis (NASH). Stimulators of soluble guanylate cyclase (sGC) enhance NO signaling; have been shown preclinically to reduce inflammation, fibrosis, and steatosis; and thu...

Descripción completa

Detalles Bibliográficos
Autores principales: Hall, Katherine C., Bernier, Sylvie G., Jacobson, Sarah, Liu, Guang, Zhang, Ping Y., Sarno, Renee, Catanzano, Victoria, Currie, Mark G., Masferrer, Jaime L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2019
Materias:
Biological Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561202/
https://www.ncbi.nlm.nih.gov/pubmed/31085647
http://dx.doi.org/10.1073/pnas.1821045116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561202/
https://www.ncbi.nlm.nih.gov/pubmed/31085647
http://dx.doi.org/10.1073/pnas.1821045116

Ejemplares similares